Drug response prediction in high-risk multiple myeloma.

导出 LinkOut

翻译打印收藏纠错

作者： A J,Vangsted ^[1] ; S,Helm-Petersen ^[2] ; J B,Cowland ^[3] ; P B,Jensen ^[4] ; P,Gimsing ^[5] ; B,Barlogie ^[6] ; S,Knudsen ^[4]

作者单位： Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: Annette.juul.vangsted@regionh.dk. ^[1] Granulocyte Research Laboratory, Copenhagen University Hospital, Copenhagen, Denmark. ^[2] Granulocyte Research Laboratory, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark. ^[3] Medical Prognosis Institute, Hørsholm, Hematology-Oncology, Denmark. ^[4] Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. ^[5] The Mount Sinai Hospital, NY, USA. ^[6]

关键词 Drug response prediction High-risk Multiple myeloma

主题词抗肿瘤药(Antineoplastic Agents);无病生存(Disease-Free Survival);基因表达谱(Gene Expression Profiling);人类(Humans);多发性骨髓瘤(Multiple Myeloma)

DOI 10.1016/j.gene.2017.10.071

PMID 29122646

发布时间 2018-01-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交